MetaCap

Beam Therapeutics (BEAM) News

NASDAQ: BEAMHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

20.90-0.04 (-0.19%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

BEAM news summary

We found 8 recent headlines mentioning Beam Therapeutics (BEAM): 0 in the past week and 7 in the past 30 days, most often from Nasdaq, GlobeNewswire, Seeking Alpha. For price context, BEAM is down 0.19% at $20.90. The most recent story, "Weekly Buzz: LLY, JNJ Win FDA Nod; SION, NNOX, Cut Jobs; PFE, ARGX Strike Deals", was published by Nasdaq on Nov 13, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Beam Therapeutics headlines

Stocks mentioned alongside BEAM

Compare BEAM